I've just read the report... it actually looks promising when you see the huge potential that Mesoblast has
But, what jumped out at me is this 7.1 estimated quarters of funding.
Yeah right - as if the CLBP trial is not going to increase the quarterly spend!
Ryoncil better be approved fast or SI will be looking for more funding soon.
Anyway, not a bad overall report - now let's see how the market digest this information
GL MSB'ers - onwards and upwards
- Forums
- ASX - By Stock
- MSB
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
MSB
mesoblast limited
Add to My Watchlist
0.93%
!
$1.63

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.082B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $6.975M | 4.265M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 707 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 7320 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11200 | 1.625 |
11 | 72699 | 1.620 |
1 | 30000 | 1.615 |
7 | 58298 | 1.610 |
3 | 96589 | 1.605 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 7000 | 1 |
1.640 | 17668 | 3 |
1.645 | 7000 | 1 |
1.650 | 37309 | 4 |
1.655 | 40000 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online